A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection

Wiener Klinische Wochenschrift

Volumn 125, Issue 15-16, 2013, Pages 453-460

  Ceylan, Bahadir ^a,b   Mete, Bilgül ^c   Fincanci, Muzaffer ^d   Aslan, Turan ^a   Akkoyunlu, Yasemin ^a   Ozguneş, Nail ^e   Colak, Onur ^e   Gunduz, Alper ^f   Senates, Ebubekir ^g   Ozaras, Resat ^c   İnci, Ayşe ^h   Tabak, Fehmi ^c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b Zafer Mahallesi   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e Radiology Department   (Turkey)

^f SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g DICLE UNIVERSITY   (Turkey)

^h Artvin State Hospital   (Turkey)

Author keywords

Blood platelets; Hepatitis B virus; Liver fibrosis

Indexed keywords

ALBUMIN; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; INDEPENDENT VARIABLE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEAN THROMBOCYTE VOLUME; PREDICTIVE VALUE; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE DISTRIBUTION WIDTH; THROMBOCYTE FUNCTION AND CHARACTERISTICS;

ADULT; CAUSALITY; COMORBIDITY; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MEAN PLATELET VOLUME; PLATELET COUNT; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 84883358200     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-013-0394-3     Document Type: Article

References (28)

1. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45:297-306.
2. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317-25.
3. Rossi E, Adams L, Prins A, Bulsara M, Boer B de, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003;49:450-4.
4. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867-73.
5. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-26.
6. Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol. 2000;15:386-90.
7. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit. 2010;16:202-5.
8. Ekiz F, Yüksel O, Koçak E, Ylmaz B, AltnbaŠ A, Çoban Š, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal. 2011;25:162-5.
9. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98:2720-55.
10. Longo DL, Henry PH. Enlargement of lymph nodes and spleen (Chapter 60). Harrison's principles of internal medicine. 17th Ed. New York: McGraw-Hill Companies; 2008. pp. 370-375.
11. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B virus related liver. Am J Gastroenterol. 2006;101:2537-45.
12. Hui A, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005;100:616-23.
13. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42:1437-45.
14. Pan JJ, Yang CF, Chu CJ, Chang FY, Lee SD. Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers. Hepatogastroenterology. 2007;54:1503-6.
15. Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 2006;13:671-7.
16. Wai C-T, Cheng CL, Wee A, Dan Y-Y, Chan E, Chua W, et al. Noninvasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006;26:666-72.
17. Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, et al. The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B. Zhonghua Nei Ke Za Zhi. 2008;47:308-12.
18. Vardar R, Gunsar F, Sertoz R, Ozacar T, Nart D, Barbet FY, et al. Hepatogastroenterology. 2010;57:908-12.
19. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969-76.
20. Chen YP, Hou JL, Dai L, Wang JL, Zhu YF. Ultrasonografic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients. Nan Fang Yi Ke Da Xue Bao. 2008;28:2157-60.
21. Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25:1569-77.
22. Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol. 1999;14:1-5.
23. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38:257-65.
24. Aster R. Pooling of platelets in the spleen: role in the pathogenesis "hypersplenic" thrombocytopenia. J Clin Invest. 1996;45:645-57.
25. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94:1918-22.
26. Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol. 2013;48:526-34. doi:10.1007/s00535-012-0656-2.
27. Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E,et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol. 2013;37:41-6. doi:10.1016/j.clinre. 2012.03035.
28. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47-58.